Everything you need to win Aptose Biosciences — in one platform.
Who to reach, what to say, and why now on Aptose Biosciences — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Aptose Biosciences — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
Aptose Signs Debt Conversion Agreement with Hanmi
Mar 28, 2025•about 1 year ago
Contract Type
agreement
San DiegoBiotechnologyHealth CareMedicalTherapeuticsresearch
Description
Aptose Biosciences Inc. announced a debt conversion agreement with Hanmi, as part of their corporate update. The agreement showcases the company's efforts to manage its financial position and pave the way for further developments in their clinical-stage precision oncology programs, particularly the tuspetinib-based triple drug frontline therapy for newly diagnosed acute myeloid leukemia (AML).
Company Information
Company
Aptose Biosciences
Location
12770 High Bluff Dr
San Diego, California, United States
About
Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies.
San DiegoBiotechnologyHealth CareMedicalTherapeuticsresearch